CSE:PREV $0.03

About Us

CSE: PREV 0.03

OPEN
0.03
VOLUME
28.2th
HIGH
0.03
LOW
0.03

Management Team

Stephen Van Deventer
Stephen Van Deventer
Chief Executive Officer & President
Stephen Van Deventer
Chief Executive Officer & President

Stephen is the Chairman and CEO of BioGene Therapeutics and PreveCeutical Medical, with over 30 years of experience in capital markets with a focus on life sciences. Stephen has started and raised millions in the capital markets space and launched companies into the public markets in Canada, the United States and Europe.

Alex McAuly, CPA
Alex McAuly, CPA
Chief Financial Officer
Alex McAuly, CPA
Chief Financial Officer

Serves as the CFO for BioGene. Alex is a Chartered Professional Accountant of Canada with vast experience in running publicly traded companies through his astute knowledge of accounting principles in North America and Europe.

Harry Parekh, PhD
Harry Parekh, PhD
Chief Science Officer
Harry Parekh, PhD
Chief Science Officer

Harry is welcomed to the BioGene team as Chief Research Officer & Scientific Founder of BioGene. Harry is currently a Director of Research and Research Group Leader at the University of Queensland, Australia. He also serves as CRO & Scientific Founder for PreveCeutical Medical.

Dr. Parekh heads the Drug/Gene Delivery Group at PACE-UQ with his team developing highly innovative and translational medicine delivery systems in-conjunction with physicians whose expertise span cancer, obesity-&-diabetes, macular disease, infectious disease and traditional (Chinese) medicine.

Louis Lapointe
Louis Lapointe
Head of Business Development
Louis Lapointe
Head of Business Development

Louis will be heading Business Development for BioGene bringing decades of experience and execution. He will lead the team in discovering revenue-generating business channels and key strategic partnerships. He is French – English bilingual, in both the spoken and written word. Mr. Lapointe has board experience in private and publicly listed companies with extensive management and strategic planning experience. Oriented toward concrete results, Mr. Lapointe has a well-rounded knowledge of sales and marketing and national and international product placement.

Kimberly Van Deventer
Kimberly Van Deventer
Executive Assistant
Kimberly Van Deventer
Executive Assistant

Ms. Van Deventer is an entrepreneur with a successful track record of accomplishment that she brings to Biogene. Motivated and determined, she was ranked the third highest-grossing female business owner in BC, Canada in 2009 and a founding member of Preveceutical Medical Inc.. Kim is a driving force behind the business and is unwavering in her commitment to bring awareness of health and disease prevention to people everywhere.

Sydney Cole
Sydney Cole
Administration Manager
Sydney Cole
Administration Manager

Sydney Cole is a founding member of Biogene Therapeutics and PreveCeutical Medical Inc.. With a decade of experience in corporate administration, bookkeeping and capital raises Ms. Cole’s organization and fortitude keep operations running smoothly.